West Pharmaceutical Debt

WST Stock  USD 344.00  16.53  5.05%   
West Pharmaceutical holds a debt-to-equity ratio of 0.121. At this time, West Pharmaceutical's Short Term Debt is comparatively stable compared to the past year. Long Term Debt Total is likely to gain to about 209.4 M in 2024, whereas Long Term Debt is likely to drop slightly above 69.2 M in 2024. . West Pharmaceutical's financial risk is the risk to West Pharmaceutical stockholders that is caused by an increase in debt.

Asset vs Debt

Equity vs Debt

West Pharmaceutical's liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. West Pharmaceutical's cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps West Stock's retail investors understand whether an upcoming fall or rise in the market will negatively affect West Pharmaceutical's stakeholders.
For most companies, including West Pharmaceutical, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for West Pharmaceutical Services, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, West Pharmaceutical's management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Price Book
9.0525
Book Value
37.96
Operating Margin
0.2232
Profit Margin
0.1737
Return On Assets
0.1
At this time, West Pharmaceutical's Total Current Liabilities is comparatively stable compared to the past year. Liabilities And Stockholders Equity is likely to gain to about 4 B in 2024, despite the fact that Change To Liabilities is likely to grow to (3.1 M).
  
Check out the analysis of West Pharmaceutical Fundamentals Over Time.

West Pharmaceutical Bond Ratings

West Pharmaceutical Services financial ratings play a critical role in determining how much West Pharmaceutical have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for West Pharmaceutical's borrowing costs.
Piotroski F Score
7
StrongView
Beneish M Score
(2.80)
Unlikely ManipulatorView

West Pharmaceutical Debt to Cash Allocation

West Pharmaceutical Services has 309 M in debt with debt to equity (D/E) ratio of 0.12, which may show that the company is not taking advantage of profits from borrowing. West Pharmaceutical has a current ratio of 3.72, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. Note however, debt could still be an excellent tool for West to invest in growth at high rates of return.

West Pharmaceutical Total Assets Over Time

West Pharmaceutical Assets Financed by Debt

The debt-to-assets ratio shows the degree to which West Pharmaceutical uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.

West Pharmaceutical Debt Ratio

    
  5.57   
It appears most of the West Pharmaceutical's assets are financed through equity. Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the West Pharmaceutical's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of West Pharmaceutical, which in turn will lower the firm's financial flexibility.

West Pharmaceutical Corporate Bonds Issued

West Short Long Term Debt Total

Short Long Term Debt Total

230.48 Million

At this time, West Pharmaceutical's Short and Long Term Debt Total is comparatively stable compared to the past year.

Understaning West Pharmaceutical Use of Financial Leverage

West Pharmaceutical's financial leverage ratio measures its total debt position, including all of its outstanding liabilities, and compares it to West Pharmaceutical's current equity. If creditors own a majority of West Pharmaceutical's assets, the company is considered highly leveraged. Understanding the composition and structure of West Pharmaceutical's outstanding bonds gives an idea of how risky it is and if it is worth investing in.
Last ReportedProjected for Next Year
Short and Long Term Debt Total309 M230.5 M
Net Debt-544.9 M-517.7 M
Short Term Debt169.4 M177.9 M
Long Term Debt72.8 M69.2 M
Long Term Debt Total186 M209.4 M
Short and Long Term Debt134 M140.7 M
Net Debt To EBITDA(0.64)(0.61)
Debt To Equity 0.08  0.07 
Interest Debt Per Share 3.14  2.42 
Debt To Assets 0.06  0.06 
Long Term Debt To Capitalization 0.02  0.02 
Total Debt To Capitalization 0.07  0.07 
Debt Equity Ratio 0.08  0.07 
Debt Ratio 0.06  0.06 
Cash Flow To Debt Ratio 3.46  3.63 
Please read more on our technical analysis page.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for West Stock Analysis

When running West Pharmaceutical's price analysis, check to measure West Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy West Pharmaceutical is operating at the current time. Most of West Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of West Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move West Pharmaceutical's price. Additionally, you may evaluate how the addition of West Pharmaceutical to your portfolios can decrease your overall portfolio volatility.

What is Financial Leverage?

Financial leverage is the use of borrowed money (debt) to finance the purchase of assets with the expectation that the income or capital gain from the new asset will exceed the cost of borrowing. In most cases, the debt provider will limit how much risk it is ready to take and indicate a limit on the extent of the leverage it will allow. In the case of asset-backed lending, the financial provider uses the assets as collateral until the borrower repays the loan. In the case of a cash flow loan, the general creditworthiness of the company is used to back the loan. The concept of leverage is common in the business world. It is mostly used to boost the returns on equity capital of a company, especially when the business is unable to increase its operating efficiency and returns on total investment. Because earnings on borrowing are higher than the interest payable on debt, the company's total earnings will increase, ultimately boosting stockholders' profits.

Leverage and Capital Costs

The debt to equity ratio plays a role in the working average cost of capital (WACC). The overall interest on debt represents the break-even point that must be obtained to profitability in a given venture. Thus, WACC is essentially the average interest an organization owes on the capital it has borrowed for leverage. Let's say equity represents 60% of borrowed capital, and debt is 40%. This results in a financial leverage calculation of 40/60, or 0.6667. The organization owes 10% on all equity and 5% on all debt. That means that the weighted average cost of capital is (.4)(5) + (.6)(10) - or 8%. For every $10,000 borrowed, this organization will owe $800 in interest. Profit must be higher than 8% on the project to offset the cost of interest and justify this leverage.

Benefits of Financial Leverage

Leverage provides the following benefits for companies:
  • Leverage is an essential tool a company's management can use to make the best financing and investment decisions.
  • It provides a variety of financing sources by which the firm can achieve its target earnings.
  • Leverage is also an essential technique in investing as it helps companies set a threshold for the expansion of business operations. For example, it can be used to recommend restrictions on business expansion once the projected return on additional investment is lower than the cost of debt.
By borrowing funds, the firm incurs a debt that must be paid. But, this debt is paid in small installments over a relatively long period of time. This frees funds for more immediate use in the stock market. For example, suppose a company can afford a new factory but will be left with negligible free cash. In that case, it may be better to finance the factory and spend the cash on hand on inputs, labor, or even hold a significant portion as a reserve against unforeseen circumstances.

The Risk of Financial Leverage

The most obvious and apparent risk of leverage is that if price changes unexpectedly, the leveraged position can lead to severe losses. For example, imagine a hedge fund seeded by $50 worth of investor money. The hedge fund borrows another $50 and buys an asset worth $100, leading to a leverage ratio of 2:1. For the investor, this is neither good nor bad -- until the asset price changes. If the asset price goes up 10 percent, the investor earns $10 on $50 of capital, a net gain of 20 percent, and is very pleased with the increased gains from the leverage. However, if the asset price crashes unexpectedly, say by 30 percent, the investor loses $30 on $50 of capital, suffering a 60 percent loss. In other words, the effect of leverage is to increase the volatility of returns and increase the effects of a price change on the asset to the bottom line while increasing the chance for profit as well.